ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 186 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $544,000 | -17.2% | 90,270 | -50.5% | 0.02% | +4.3% |
| Q3 2019 | $657,000 | +242.2% | 182,438 | +154.9% | 0.02% | +360.0% |
| Q2 2019 | $192,000 | +284.0% | 71,559 | +320.2% | 0.01% | +150.0% |
| Q1 2019 | $50,000 | -60.0% | 17,028 | -78.4% | 0.00% | 0.0% |
| Q4 2018 | $125,000 | -9.4% | 78,762 | +110.6% | 0.00% | -33.3% |
| Q3 2018 | $138,000 | -80.5% | 37,403 | -84.8% | 0.00% | -83.3% |
| Q4 2017 | $708,000 | +122.6% | 245,820 | +246.9% | 0.02% | +125.0% |
| Q3 2017 | $318,000 | +3.9% | 70,868 | +6.2% | 0.01% | -11.1% |
| Q2 2017 | $306,000 | -18.2% | 66,703 | -24.9% | 0.01% | -25.0% |
| Q1 2017 | $374,000 | -53.6% | 88,842 | -54.5% | 0.01% | -42.9% |
| Q4 2016 | $806,000 | -3.0% | 195,149 | +90.2% | 0.02% | +10.5% |
| Q3 2016 | $831,000 | +436.1% | 102,612 | +417.0% | 0.02% | +533.3% |
| Q2 2016 | $155,000 | -49.7% | 19,846 | -50.3% | 0.00% | -62.5% |
| Q1 2016 | $308,000 | +234.8% | 39,959 | +284.2% | 0.01% | +166.7% |
| Q2 2015 | $92,000 | -46.2% | 10,400 | -25.4% | 0.00% | -50.0% |
| Q4 2014 | $171,000 | -62.1% | 13,942 | -69.2% | 0.01% | -62.5% |
| Q3 2014 | $451,000 | +124.4% | 45,217 | +70.0% | 0.02% | +100.0% |
| Q2 2014 | $201,000 | +24.1% | 26,592 | -45.5% | 0.01% | 0.0% |
| Q4 2013 | $162,000 | – | 48,767 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |